Found: 5
Select item for more details and to access through your institution.
Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01438-z
- By:
- Publication type:
- Article
Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Bevacizumab in Association With de Gramont 5-Fluorouracil/Folinic Acid in Patients With Oxaliplatin-, Irinotecan-, and Cetuximab-Refractory Colorectal Cancer.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 20, p. 4849, doi. 10.1002/cncr.24540
- By:
- Publication type:
- Article
Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer.
- Published in:
- BMC Cancer, 2006, v. 6, p. 42, doi. 10.1186/1471-2407-6-42
- By:
- Publication type:
- Article
Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1661, doi. 10.3390/cancers11111661
- By:
- Publication type:
- Article